本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Verrica Pharmaceuticals Inc.

4.60
-0.1800-3.77%
成交量:4.14萬
成交額:19.33萬
市值:7,902.25萬
市盈率:-2.64
高:4.75
開:4.75
低:4.56
收:4.78
52周最高:9.82
52周最低:3.28
股本:1,717.88萬
流通股本:677.74萬
量比:0.76
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-1.7400
每股收益(LYR):-1.6791
淨資產收益率:-240.35%
總資產收益率:-43.98%
市淨率:18.35
市盈率(LYR):-2.74

資料載入中...

2024/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities